{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:17:58Z","timestamp":1792423078490,"version":"4.5.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2020,12,8]]},"DOI":"10.1001\/jama.2020.22258","type":"journal-article","created":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T10:30:26Z","timestamp":1605436226000},"page":"2268","source":"Crossref","is-referenced-by-count":987,"title":["Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk"],"prefix":"10.1001","volume":"324","author":[{"given":"Stephen J.","family":"Nicholls","sequence":"first","affiliation":[{"name":"Monash Cardiovascular Research Centre, Victorian Heart Institute, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Michael","family":"Lincoff","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Coordinating Center for Clinical Research, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Garcia","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Coordinating Center for Clinical Research, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna","family":"Bash","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Coordinating Center for Clinical Research, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Barter","sequence":"additional","affiliation":[{"name":"University of New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Davidson","sequence":"additional","affiliation":[{"name":"University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J. P.","family":"Kastelein","sequence":"additional","affiliation":[{"name":"Academic Medical Center, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Koenig","sequence":"additional","affiliation":[{"name":"Deutsches Herzzentrum M\u00fcnchen, Technische Universit\u00e4t M\u00fcnchen, DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany and Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren K.","family":"McGuire","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariush","family":"Mozaffarian","sequence":"additional","affiliation":[{"name":"Friedman School of Nutrition Science and Policy, Tufts University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M","family":"Ridker","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Disease Prevention, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausik K.","family":"Ray","sequence":"additional","affiliation":[{"name":"Imperial College of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Katona","sequence":"additional","affiliation":[{"name":"AstraZeneca BioPharmaceuticals R&D, Late-stage Development, Cardiovascular, Renal and Metabolic, Gaithersburg, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Himmelmann","sequence":"additional","affiliation":[{"name":"AstraZeneca BioPharmaceuticals R&D, Late-stage Development, Cardiovascular, Renal and Metabolic, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larrye E.","family":"Loss","sequence":"additional","affiliation":[{"name":"AstraZeneca BioPharmaceuticals R&D, Late-stage Development, Cardiovascular, Renal and Metabolic, Gaithersburg, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rensfeldt","sequence":"additional","affiliation":[{"name":"AstraZeneca BioPharmaceuticals R&D, Late-stage Development, Cardiovascular, Renal and Metabolic, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"Lundstr\u00f6m","sequence":"additional","affiliation":[{"name":"AstraZeneca BioPharmaceuticals R&D, Late-stage Development, Cardiovascular, Renal and Metabolic, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Agrawal","sequence":"additional","affiliation":[{"name":"AstraZeneca BioPharmaceuticals R&D, Late-stage Development, Cardiovascular, Renal and Metabolic, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venu","family":"Menon","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Coordinating Center for Clinical Research, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Wolski","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Coordinating Center for Clinical Research, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Nissen","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Coordinating Center for Clinical Research, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"joi200120r1","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1001\/jamainternmed.2016.2925","article-title":"?-3 Polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies.","volume":"176","author":"Del Gobbo","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"5","key":"joi200120r2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/advances\/nmaa029","article-title":"Fish consumption and the risk of chronic disease: an umbrella review of meta-analyses of prospective cohort studies.","volume":"11","author":"Jayedi","year":"2020","journal-title":"Adv Nutr"},{"issue":"7","key":"joi200120r3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.7326\/0003-4819-158-7-201304020-00003","article-title":"Plasma phospholipid long-chain ?-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.","volume":"158","author":"Mozaffarian","year":"2013","journal-title":"Ann Intern Med"},{"issue":"7","key":"joi200120r4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041046","article-title":"Serum long-chain n-3 polyunsaturated fatty acids, mercury, and risk of sudden cardiac death in men: a prospective population-based study.","volume":"7","author":"Virtanen","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"joi200120r5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jacc.2009.02.084","article-title":"Omega-3 polyunsaturated fatty acids and cardiovascular diseases.","volume":"54","author":"Lavie","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"joi200120r6","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","article-title":"Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.","volume":"58","author":"Mozaffarian","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"9177","key":"joi200120r7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.","volume":"354","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"joi200120r8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/jamacardio.2017.5205","article-title":"Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77?917 individuals.","volume":"3","author":"Aung","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"4","key":"joi200120r9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1056\/NEJMoa1203859","article-title":"n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.","volume":"367","author":"Bosch","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"joi200120r10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2008.06.003","article-title":"Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).","volume":"200","author":"Saito","year":"2008","journal-title":"Atherosclerosis"},{"issue":"1","key":"joi200120r11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia.","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"16","key":"joi200120r12","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJMoa1804989","article-title":"Effects of n-3 fatty acid supplements in diabetes mellitus.","volume":"379","author":"Bowman","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"joi200120r13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1811403","article-title":"Marine n-3 fatty acids and prevention of cardiovascular disease and cancer.","volume":"380","author":"Manson","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"joi200120r14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jacl.2013.10.003","article-title":"Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.","volume":"8","author":"Kastelein","year":"2014","journal-title":"J Clin Lipidol"},{"issue":"9","key":"joi200120r15","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.clinthera.2013.07.420","article-title":"A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).","volume":"35","author":"Maki","year":"2013","journal-title":"Clin Ther"},{"issue":"10","key":"joi200120r16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/clc.23055","article-title":"Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: rationale and design of the STRENGTH trial.","volume":"41","author":"Nicholls","year":"2018","journal-title":"Clin Cardiol"},{"issue":"6","key":"joi200120r17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11883-010-0133-4","article-title":"Dietary monounsaturated fatty acids appear not to provide cardioprotection.","volume":"12","author":"Degirolamo","year":"2010","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"joi200120r18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000252","article-title":"Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials.","volume":"7","author":"Mozaffarian","year":"2010","journal-title":"PLoS Med"},{"issue":"12","key":"joi200120r19","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/ajcn\/33.12.2657","article-title":"The composition of the Eskimo food in north western Greenland.","volume":"33","author":"Bang","year":"1980","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"joi200120r20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3181\/00379727-200-43413","article-title":"Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial.","volume":"200","author":"Dolecek","year":"1992","journal-title":"Proc Soc Exp Biol Med"},{"issue":"79","key":"joi200120r21","first-page":"1","article-title":"Trends in the use of complementary health approaches among adults: United States, 2002-2012.","author":"Clarke","year":"2015","journal-title":"Natl Health Stat Report"},{"issue":"14","key":"joi200120r22","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1001\/jama.2016.14403","article-title":"Trends in dietary supplement use among US adults from 1999-2012.","volume":"316","author":"Kantor","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"joi200120r24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5551\/jat.5876","article-title":"Relationships between plasma fatty acid composition and coronary artery disease.","volume":"18","author":"Itakura","year":"2011","journal-title":"J Atheroscler Thromb"},{"issue":"9841","key":"joi200120r26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"joi200120r27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000759","article-title":"Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials.","volume":"3","author":"Thanassoulis","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"joi200120r28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy.","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"joi200120r29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4196\/kjpp.2009.13.4.301","article-title":"DHA and EPA down-regulate COX-2 expression through suppression of NF-kappaB activity in LPS-treated human umbilical vein endothelial cells.","volume":"13","author":"Lee","year":"2009","journal-title":"Korean J Physiol Pharmacol"},{"issue":"7","key":"joi200120r30","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0022-2828(03)00120-2","article-title":"EPA and DHA attenuate ox-LDL-induced expression of adhesion molecules in human coronary artery endothelial cells via protein kinase B pathway.","volume":"35","author":"Chen","year":"2003","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"joi200120r31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192484","article-title":"Characterisation of the vasodilation effects of DHA and EPA, n-3 PUFAs (fish oils), in rat aorta and mesenteric resistance arteries.","volume":"13","author":"Limbu","year":"2018","journal-title":"PLoS One"},{"key":"joi200120r32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jnutbio.2016.02.010","article-title":"Protective role of n6\/n3 PUFA supplementation with varying DHA\/EPA ratios against atherosclerosis in mice.","volume":"32","author":"Liu","year":"2016","journal-title":"J Nutr Biochem"},{"issue":"3","key":"joi200120r33","doi-asserted-by":"publisher","first-page":"614S","DOI":"10.3945\/jn.111.149633","article-title":"(n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?","volume":"142","author":"Mozaffarian","year":"2012","journal-title":"J Nutr"},{"issue":"1","key":"joi200120r34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ypmed.2004.02.030","article-title":"The Omega-3 Index: a new risk factor for death from coronary heart disease?","volume":"39","author":"Harris","year":"2004","journal-title":"Prev Med"},{"key":"joi200120r23","unstructured":"FDA briefing document: Endocrinologic and Metabolic Drugs Advisory Committee meeting. November 14, 2019. Accessed October 28, 2020. https:\/\/www.fda.gov\/media\/132477\/download"},{"key":"joi200120r25","unstructured":"Reduction of cardiovascular events with icosapent ethyl-intervention trial (REDUCE-IT). American College of Cardiology. June 15, 2020. Accessed August 2, 2020. https:\/\/www.acc.org\/latest-in-cardiology\/clinical-trials\/2018\/11\/08\/22\/48\/reduce-it"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2773120\/jama_nicholls_2020_oi_200120_26599_1608141606.07369.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T00:44:13Z","timestamp":1608338653000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2773120"}},"subtitle":["The STRENGTH Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,12,8]]},"references-count":34,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2020,12,8]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.22258","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739037636.793581123","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.739037636.793581318","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.739037636.793581405","asserted-by":"object"}]},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,8]]}}}